dendormissement

Dendormissement is a French term describing the onset of sleep, the transition from wakefulness to sleep. In medical and scientific usage, it refers to the moment a person begins to fall asleep and enter the early stages of sleep, often associated with subjective sleepiness and the initiation of sleep.

Physiologically, dendormissement involves a reduction in wake-promoting brain activity and the emergence of sleep-related activity. It is commonly linked to the initial sleep stage (light sleep, stage N1 on polysomnography) characterized by slower brain waves, relaxed muscle tone, and slower breathing. The timing and ease of dendormissement are influenced by circadian rhythms, prior sleep debt, environment, and overall health.

Causes and associations include normal variation in sleepiness across the day, fatigue from sleep deprivation, shift work, and extended wakefulness. It can be facilitated or hindered by substances such as caffeine, alcohol, sedatives, and certain medications. In clinical contexts, abnormal or accelerated dendormissement may be seen in sleep disorders like narcolepsy, insomnia with difficulty maintaining sleep, or disorders causing excessive daytime sleepiness.

Clinical relevance involves assessing sleep onset latency and the patient’s experience of falling asleep. It is also a focal point in evaluating the effects of medications and in sleep studies. Dendormissement can be a normal part of the sleep cycle or a feature of pathological sleepiness requiring medical evaluation.

Management focuses on sleep hygiene and treating underlying conditions. Approaches include regular sleep schedules, a conducive sleep environment, limiting sedatives, and addressing disorders that affect onset of sleep. Safety considerations, especially regarding activities like driving, are important when dendormissement occurs rapidly or unexpectedly.